KELSEY FRANXMAN: Open Payments
NPI 1134985534 · CRESTVIEW HILLS, KY. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$767 in 42 payments from 11 companies in 2025. Trend: 2023 $0 · 2024 $822 · 2025 $767
Food & beverage: $767
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 16 | $282 |
| QOL Medical, LLC | 4 | $96 |
| Takeda Pharmaceuticals U.S.A., Inc. | 5 | $96 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 4 | $83 |
| Janssen Biotech, Inc. | 3 | $50 |
| Lilly USA, LLC | 2 | $36 |
| Ardelyx, Inc. | 2 | $35 |
| Organon LLC | 2 | $31 |
| Regeneron Healthcare Solutions, Inc. | 1 | $26 |
| Braintree Laboratories, Inc. | 1 | $18 |
Products named: RINVOQ, Sucraid, XIFAXAN, ENTYVIO, VIBERZI, TREMFYA, OMVOH, IBSRELA.
Industry payments across KY — which companies pay providers there.
